These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

212 related items for PubMed ID: 15924412

  • 1. Mouse estrogen receptor beta isoforms exhibit differences in ligand selectivity and coactivator recruitment.
    Zhao C, Toresson G, Xu L, Koehler KF, Gustafsson JA, Dahlman-Wright K.
    Biochemistry; 2005 Jun 07; 44(22):7936-44. PubMed ID: 15924412
    [Abstract] [Full Text] [Related]

  • 2. Functional characteristics of a novel murine estrogen receptor-beta isoform, estrogen receptor-beta 2.
    Lu B, Leygue E, Dotzlaw H, Murphy LJ, Murphy LC.
    J Mol Endocrinol; 2000 Oct 07; 25(2):229-42. PubMed ID: 11013349
    [Abstract] [Full Text] [Related]

  • 3. Evaluation of ligand selectivity using reporter cell lines stably expressing estrogen receptor alpha or beta.
    Escande A, Pillon A, Servant N, Cravedi JP, Larrea F, Muhn P, Nicolas JC, Cavaillès V, Balaguer P.
    Biochem Pharmacol; 2006 May 14; 71(10):1459-69. PubMed ID: 16554039
    [Abstract] [Full Text] [Related]

  • 4. Capacity of type I and II ligands to confer to estrogen receptor alpha an appropriate conformation for the recruitment of coactivators containing a LxxLL motif-Relationship with the regulation of receptor level and ERE-dependent transcription in MCF-7 cells.
    Bourgoin-Voillard S, Gallo D, Laïos I, Cleeren A, Bali LE, Jacquot Y, Nonclercq D, Laurent G, Tabet JC, Leclercq G.
    Biochem Pharmacol; 2010 Mar 01; 79(5):746-57. PubMed ID: 19879249
    [Abstract] [Full Text] [Related]

  • 5. Differential Activation of a Mouse Estrogen Receptor β Isoform (mERβ2) with Endocrine-Disrupting Chemicals (EDCs).
    Donoghue LJ, Neufeld TI, Li Y, Arao Y, Coons LA, Korach KS.
    Environ Health Perspect; 2017 Apr 01; 125(4):634-642. PubMed ID: 27634370
    [Abstract] [Full Text] [Related]

  • 6. CCDC62/ERAP75 functions as a coactivator to enhance estrogen receptor beta-mediated transactivation and target gene expression in prostate cancer cells.
    Chen M, Ni J, Chang HC, Lin CY, Muyan M, Yeh S.
    Carcinogenesis; 2009 May 01; 30(5):841-50. PubMed ID: 19126643
    [Abstract] [Full Text] [Related]

  • 7. A homogeneous in vitro functional assay for estrogen receptors: coactivator recruitment.
    Liu J, Knappenberger KS, Kack H, Andersson G, Nilsson E, Dartsch C, Scott CW.
    Mol Endocrinol; 2003 Mar 01; 17(3):346-55. PubMed ID: 12554768
    [Abstract] [Full Text] [Related]

  • 8. Use of binding energy in comparative molecular field analysis of isoform selective estrogen receptor ligands.
    Wolohan P, Reichert DE.
    J Mol Graph Model; 2004 Sep 01; 23(1):23-38. PubMed ID: 15331051
    [Abstract] [Full Text] [Related]

  • 9. Detection and localization of an estrogen receptor beta splice variant protein (ERbeta2) in the adult female rat forebrain and midbrain regions.
    Chung WC, Pak TR, Suzuki S, Pouliot WA, Andersen ME, Handa RJ.
    J Comp Neurol; 2007 Nov 20; 505(3):249-67. PubMed ID: 17879269
    [Abstract] [Full Text] [Related]

  • 10. Transcriptional activity of estrogen receptors ERalpha and ERbeta in the EtC.1 cerebellar granule cell line.
    Gottfried-Blackmore A, Croft G, McEwen BS, Bulloch K.
    Brain Res; 2007 Dec 20; 1186():41-7. PubMed ID: 18021758
    [Abstract] [Full Text] [Related]

  • 11. Ligand unbinding from the estrogen receptor: a computational study of pathways and ligand specificity.
    Burendahl S, Danciulescu C, Nilsson L.
    Proteins; 2009 Dec 20; 77(4):842-56. PubMed ID: 19626711
    [Abstract] [Full Text] [Related]

  • 12. Pyrazolo[1,5-a]pyrimidines: estrogen receptor ligands possessing estrogen receptor beta antagonist activity.
    Compton DR, Sheng S, Carlson KE, Rebacz NA, Lee IY, Katzenellenbogen BS, Katzenellenbogen JA.
    J Med Chem; 2004 Nov 18; 47(24):5872-93. PubMed ID: 15537344
    [Abstract] [Full Text] [Related]

  • 13. Potential of endogenous estrogen receptor beta to influence the selective ER modulator ERbeta complex.
    Chen B, Gajdos C, Dardes R, Kidwai N, Johnston SR, Dowsett M, Jordan VC.
    Int J Oncol; 2005 Aug 18; 27(2):327-35. PubMed ID: 16010412
    [Abstract] [Full Text] [Related]

  • 14. Analysis of ligand-dependent recruitment of coactivator peptides to estrogen receptor using fluorescence polarization.
    Ozers MS, Ervin KM, Steffen CL, Fronczak JA, Lebakken CS, Carnahan KA, Lowery RG, Burke TJ.
    Mol Endocrinol; 2005 Jan 18; 19(1):25-34. PubMed ID: 15375189
    [Abstract] [Full Text] [Related]

  • 15. Insights into ligand selectivity in estrogen receptor isoforms: molecular dynamics simulations and binding free energy calculations.
    Zeng J, Li W, Zhao Y, Liu G, Tang Y, Jiang H.
    J Phys Chem B; 2008 Mar 06; 112(9):2719-26. PubMed ID: 18266357
    [Abstract] [Full Text] [Related]

  • 16. Ligand-selective transactivation and transrepression via the glucocorticoid receptor: role of cofactor interaction.
    Ronacher K, Hadley K, Avenant C, Stubsrud E, Simons SS, Louw A, Hapgood JP.
    Mol Cell Endocrinol; 2009 Feb 27; 299(2):219-31. PubMed ID: 19007848
    [Abstract] [Full Text] [Related]

  • 17. Coactivator peptides have a differential stabilizing effect on the binding of estrogens and antiestrogens with the estrogen receptor.
    Gee AC, Carlson KE, Martini PG, Katzenellenbogen BS, Katzenellenbogen JA.
    Mol Endocrinol; 1999 Nov 27; 13(11):1912-23. PubMed ID: 10551784
    [Abstract] [Full Text] [Related]

  • 18. Isoform-selective interactions between estrogen receptors and steroid receptor coactivators promoted by estradiol and ErbB-2 signaling in living cells.
    Bai Y, Giguére V.
    Mol Endocrinol; 2003 Apr 27; 17(4):589-99. PubMed ID: 12554772
    [Abstract] [Full Text] [Related]

  • 19. Synthesis of an estrogen receptor beta-selective radioligand: 5-[18F]fluoro-(2R,3S)-2,3-bis(4-hydroxyphenyl)pentanenitrile and comparison of in vivo distribution with 16alpha-[18F]fluoro-17beta-estradiol.
    Yoo J, Dence CS, Sharp TL, Katzenellenbogen JA, Welch MJ.
    J Med Chem; 2005 Oct 06; 48(20):6366-78. PubMed ID: 16190762
    [Abstract] [Full Text] [Related]

  • 20. Structure of the ligand-binding domain of oestrogen receptor beta in the presence of a partial agonist and a full antagonist.
    Pike AC, Brzozowski AM, Hubbard RE, Bonn T, Thorsell AG, Engström O, Ljunggren J, Gustafsson JA, Carlquist M.
    EMBO J; 1999 Sep 01; 18(17):4608-18. PubMed ID: 10469641
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.